FDA Commissioner's Office Reduced 12% Under Henney Restructuring Plan
This article was originally published in The Gray Sheet
Executive Summary
A recently announced plan to restructure the FDA Office of the Commissioner would cut its size by 12%, FDA Commissioner Jane Henney, MD, estimated April 27 at a Senate Appropriations/Agriculture Subcommittee hearing on the agency's FY 2000 budget.